EX-10.32 2 a15-1794_1ex10d32.htm EX-10.32 THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION....Product Development and Clinical Supply Agreement • May 5th, 2020 • New York
THIS PRODUCT DEVELOPMENT AND CLINICAL SUPPLY AGREEMENT (this “Agreement”) is made effective as of the 23rd day of October, 2014 (the “Effective Date”) by and between BAXTER PHARMACEUTICAL SOLUTIONS LLC, a Delaware limited liability company having a place of business at 927 South Curry Pike, Bloomington, Indiana 47403 (“Baxter”), and GENOCEA BIOSCIENCE, INC., a Delaware corporation having a principal place of business at Cambridge Discovery Park, 100 Acorn Park Dr., 5th Floor, Cambridge, MA, 02140 (“Client”).
Product Development and Clinical Supply AgreementProduct Development and Clinical Supply Agreement • September 27th, 2007 • Biomira CORP • Services-commercial physical & biological research • Indiana
BIOMIRA USA, a Corporation organized and existing under the laws of Delaware, with its principal offices located at 1002 East Park Boulevard, Cranbury, New Jersey 08512 (hereinafter referred to as "CLIENT")
